These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4807057)

  • 1. [Relations between fibrinolysis and human atherosclerosis. Tissue activator of plasminogen of the arterial wall].
    Tesi M; Caramelli L
    Boll Soc Ital Cardiol; 1973; 18(2):181-94. PubMed ID: 4807057
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen-activator of the arterial wall in occluded arteries.
    Donner L; Klener P; Vodákowá I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):141-7. PubMed ID: 6157618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors of the fibrinolysis of the vascular wall in patients with different severity of atherosclerosis and of different age].
    Kovalenko AN
    Biull Eksp Biol Med; 1982 Jan; 93(1):26-8. PubMed ID: 7199953
    [No Abstract]   [Full Text] [Related]  

  • 4. Some fibrinolytic properties of the human arteries and veins walls.
    Donner L; Vodáková L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):451-9. PubMed ID: 2431965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasminogen activator content of the arterial wall in occlusive arterial diseases.
    Constantini R; Hilbe G; Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1972 Jul; 27(3):649-54. PubMed ID: 4662619
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis and atherosclerosis.
    Collen D; Juhan-Vague I
    Semin Thromb Hemost; 1988 Apr; 14(2):180-3. PubMed ID: 3144739
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
    Maksimenko AV
    Mol Biol (Mosk); 1995; 29(1):38-60. PubMed ID: 7723763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased fibrinolytic activity in human atherosclerotic vessels.
    Ljungnér H; Bergqvist D
    Atherosclerosis; 1984 Jan; 50(1):113-6. PubMed ID: 6538086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fibrinolytic activity of recombinant tissue-type plasminogen activator in the plasma of various primate species.
    Lijnen HR; Marafino BJ; Collen D
    Thromb Haemost; 1984 Dec; 52(3):308-10. PubMed ID: 6543405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Place and role of tissue plasminogen activator in the fibrinolysis process].
    Wilczyńska M; Cierniewski C
    Postepy Hig Med Dosw; 1984; 38(4):481-97. PubMed ID: 6399108
    [No Abstract]   [Full Text] [Related]  

  • 19. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
    Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
    Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissue.
    Juhan-Vague I; Alessi MC
    Thromb Haemost; 1999 Aug; 82(2):832-6. PubMed ID: 10605790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.